Christi Shaw has spent more than 30 years in executive leadership roles across the industry’s largest pharmaceutical companies and a broad range of therapeutic areas. Most recently, Ms. Shaw served as the Chief Executive Officer of Kite Pharma (a Gilead company). Prior to joining Kite, Ms. Shaw served as Senior Vice President of Eli Lilly Company and President of Lilly Bio-Medicines, the business within Eli Lilly Company that comprises neuroscience and immunology.

Previously, Ms. Shaw was an executive at Novartis Pharmaceutical Corporation, including as U.S. country head and President of Novartis Pharmaceutical Corporation and as North American region head of Novartis Oncology, and earlier held leadership roles of increasing responsibility at Johnson & Johnson, Inc.

Ms. Shaw currently serves on the board of directors of Avantor, Beam Therapeutics, ReAlta Lifesciences, and is an advisor to Cellares and the Iowa State Ivy College of Business. Additionally, she is the co-founder of the More Moments More Memories Foundation to assist people with cancer and their caregivers.

Ms. Shaw holds an M.B.A. from the University of Wisconsin and a B.B.A. in Marketing from Iowa State University.